Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: A multicentre study

Journal of Human Hypertension

Volumn 18, Issue 1, 2004, Pages 53-59

  Galzerano, Domenico ^a   Tammaro, P ^a   Cerciello, A ^b   Breglio, R ^a   Mallardo, M ^a   Lama, D ^c   Tuccillo, B ^d   Capogrosso, P ^a  

^a San Gennaro Hospital   (Italy)

^b San Giovanni Bosco Hospital   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Loreto Mare Hospital   (Italy)

Author keywords

Angiotensin II receptor blocker; Hydrochlorothiazide; Left ventricular hypertrophy; Left ventricular mass index; Telmisartan; Three dimensional echocardiography

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TELMISARTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; LABORATORY TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VERTIGO;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; TREATMENT OUTCOME;

EID: 0842264751     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001637     Document Type: Article

References (32)

1. Verdecchia P et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
2. Verdecchia P et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: The MAVI study. J Am Coll Cardiol 2001; 38: 1829-1835.
3. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-101.
4. Hollenberg NK, Fisher ND, Price DA. Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system. Hypertension 1998; 32: 387-392.
5. Semple PF. Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors. J Hypertens 1995; 13 (Suppl 3): S17-S21.
6. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 2002; 89 (Suppl 2A): 3A-10A.
7. Dahlöf B. Left ventricular hypertrophy and angiotensin II antagonists. Am J Hypertens 2001; 14: 174-182.
8. Okin PM et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study. Circulation 2003; 108: 684-690.
9. Devereux RB et al. Prognostic significance of left ventricular hypertrophy during treatment of hypertension: The LIFE Study. J Am Coll Cardiol 2003; 41 (Suppl. A): 228A [abstract 1011-135].
10. Maillard MP et al. In vitro and in vivo characterisation of the activity of telmisartan: An insurmountable angiotensin II receptor antagonist. J Pharmacol Exp Ther 2002; 302: 1089-1095.
11. Sharpe M, Jarvis B, Goa KL. Telmisartan: A review of its use in hypertension. Drugs 2001; 61: 1501-1529
12. Lijnen PJ, Petrov VV, Fagard RH. Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors. J Renin Angiotensin Aldosterone Syst 2001; 2: 117-122.
13. Böhm M et al. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade. Mol Cell Biochem 1996; 163/164: 217-221.
14. 1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain. Clin Exp Hypertens 1998; 20: 205-221.
15. Wienen W, Richard S, Champeroux P, Audeval-Gerard C. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. J Renin Angiotensin Aldosterone Syst 2001; 2: 31-36.
16. Ivanova OV et al. Angiotensin II receptor blocker telmisartan: Effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension. Kardiologiia 2002; 42: 45-49.
17. Martina B et al. Effects of telmisartan and losartan on left ventricular mass in mild-to-moderate hypertension. Cardiology 2003; 99: 160-170.
18. Papademetriou V. Effect of diuretics on cardiac arrhythmias and left ventricular hypertrophy in hypertension. Cardiology 1994; 84 (Suppl 2): 43-47.
19. Klingbeil AU et al. A meta-analysis of the effects of treatment of left ventricular mass in essential hypertension. Am J Med 2003; 115: 41-46.
20. Gopal AS et al. Freehand three-dimensional echocardiography for determination of left ventricular volume and mass in patients with abnormal ventricles: Comparison with magnetic resonance imaging. J Am Soc Echocardiogr 1997; 10: 853-861.
21. Bachenberg TC, Shub C, Hauck AJ, Edwards WD. Can anatomical left ventricular mass be estimated reliably by M-mode echocardiography? A clinicopathological study of ninety-three patients. Echocardiography 1991; 8: 9-15.
22. Richtscheid M, Grimm M, Sakas G. Freehand scanning for precordial data acquisition in three-dimensional echocardiography. In: Roeslandt JRTC (ed). Three-dimensional Echocardiography of the Heart and Coronary Arteries. Van Zuiden Communications: Alphen aan den Rijn, 2000, pp 31-36.
23. Galzerano D et al. Reproducibility of assessment of left ventricular mass and function by a novel echocardiographic technique: Freehand three-dimensional echocardiography. J Am Coll Cardiol 2002; 39: 40B [abstract].
24. Mannaerts HF et al. Quantification of left ventricular volumes and ejection fraction using freehand three-dimensional echocardiography: Comparison with magnetic resonance imaging. J Am Soc Echocardiogr 2003; 16: 101-109.
25. Neutel J, Smith D. Evaluation of angiotensin II receptor blockers for 24-h blood pressure control: Meta-analysis of a clinical database. J Clin Hypertens 2003; 5: 58-63.
26. Shimada K et al. Early morning surge in blood pressure. Blood Press Monit 2001; 6: 349-353.
27. Mancia G et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95: 1464-1470.
28. Devereux RB et al. Progressive hypertrophy regression with sustained pressure reduction in hypertension: The Losartan Intervention For Endpoint Reduction study. J Hypertens 2002; 20: 1445-1450.
29. Tedesco MA et al. Effects of losartan on hypertension and left ventricular mass: A long-term study. J Hum Hypertens 1998; 12: 505-510.
30. Friedrich MG et al. Rationale and design of telmisartan effectiveness on left ventricular mass reduction (TELMAR) study. J Hypertens 2003; 21 (Suppl. 4): S185 [abstract P2.226].
31. Galzerano D, Tuccillo B, Capogrosso P. Precordial dynamic freehand three-dimensional echocardiography: Accuracy and feasibility of a new technique for assessing left ventricular volume and mass: Comparison with NMR. Ital Heart J 2001; 2 (Suppl 2): C176 [abstract].
32. McCarron DA. Step-one antihypertensive therapy: A comparison of a centrally acting agent and a diuretic. J Cardiovasc Pharmacol 1984; 6 (Suppl 5): S853-S858.